Abstract
A double-blind trial comparing lincomycin hydrochloride (Mycivin) and placebo in 22 patients with Reiter's disease showed no significant difference in clinical or laboratory findings between the two groups. It is concluded that lincomycin hydrochloride is no more effective than placebo in the treatment of Reiter's disease. © 1969, British Medical Journal Publishing Group. All rights reserved.
Cite
CITATION STYLE
APA
Whaley, K., Downie, W. W., Dick, W. C., Nuki, G., Schofield, C. B. S., & Anderson, J. (1969). Clinical Trial of Lincomycin Hydrochloride in Reiter’s Disease. British Medical Journal, 2(5654), 421–422. https://doi.org/10.1136/bmj.2.5654.421
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free